Print

Athersys, Inc. Receives Cell Therapy Manufacturing Award  
11/1/2012 7:02:24 AM

CLEVELAND, Nov. 1, 2012 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced that its subsidiary, ReGenesys BVBA, recently received the BioProcess International Award for the "Technical Application of the Decade" in Manufacturing for its use of an automated bioreactor system for the production of MultiStem®, Athersys' proprietary, off-the-shelf stem cell therapy. Award winners in other categories included Bayer Healthcare and Technology Services and GE Healthcare, among others.